Natural Killer Cell Therapy Market Size, Share, Growth, and Industry Analysis, By Type ( NK Cell Therapies,NK Cell Directed Antibodies ), By Application ( Cancer,Gastrointestinal Diseases,Others ), Regional Insights and Forecast to 2035

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Natural Killer Cell Therapy Market Size (2020-2031)
2.1.2 Natural Killer Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Natural Killer Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 Natural Killer Cell Therapy Segment by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Directed Antibodies
2.3 Natural Killer Cell Therapy Market Size by Type
2.3.1 Natural Killer Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Natural Killer Cell Therapy Market Size Market Share by Type (2020-2025)
2.4 Natural Killer Cell Therapy Segment by Application
2.4.1 Cancer
2.4.2 Gastrointestinal Diseases
2.4.3 Others
2.5 Natural Killer Cell Therapy Market Size by Application
2.5.1 Natural Killer Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Natural Killer Cell Therapy Market Size Market Share by Application (2020-2025)
3 Natural Killer Cell Therapy Market Size by Player
3.1 Natural Killer Cell Therapy Market Size Market Share by Player
3.1.1 Global Natural Killer Cell Therapy Revenue by Player (2020-2025)
3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Natural Killer Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Natural Killer Cell Therapy by Region
4.1 Natural Killer Cell Therapy Market Size by Region (2020-2025)
4.2 Global Natural Killer Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Natural Killer Cell Therapy Market Size Growth (2020-2025)
4.4 APAC Natural Killer Cell Therapy Market Size Growth (2020-2025)
4.5 Europe Natural Killer Cell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Natural Killer Cell Therapy Market Size Growth (2020-2025)
5 Americas
5.1 Americas Natural Killer Cell Therapy Market Size by Country (2020-2025)
5.2 Americas Natural Killer Cell Therapy Market Size by Type (2020-2025)
5.3 Americas Natural Killer Cell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Natural Killer Cell Therapy Market Size by Region (2020-2025)
6.2 APAC Natural Killer Cell Therapy Market Size by Type (2020-2025)
6.3 APAC Natural Killer Cell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Natural Killer Cell Therapy Market Size by Country (2020-2025)
7.2 Europe Natural Killer Cell Therapy Market Size by Type (2020-2025)
7.3 Europe Natural Killer Cell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Natural Killer Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Natural Killer Cell Therapy Market Forecast
10.1 Global Natural Killer Cell Therapy Forecast by Region (2026-2031)
10.1.1 Global Natural Killer Cell Therapy Forecast by Region (2026-2031)
10.1.2 Americas Natural Killer Cell Therapy Forecast
10.1.3 APAC Natural Killer Cell Therapy Forecast
10.1.4 Europe Natural Killer Cell Therapy Forecast
10.1.5 Middle East & Africa Natural Killer Cell Therapy Forecast
10.2 Americas Natural Killer Cell Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Natural Killer Cell Therapy Forecast
10.2.2 Canada Market Natural Killer Cell Therapy Forecast
10.2.3 Mexico Market Natural Killer Cell Therapy Forecast
10.2.4 Brazil Market Natural Killer Cell Therapy Forecast
10.3 APAC Natural Killer Cell Therapy Forecast by Region (2026-2031)
10.3.1 China Natural Killer Cell Therapy Market Forecast
10.3.2 Japan Market Natural Killer Cell Therapy Forecast
10.3.3 Korea Market Natural Killer Cell Therapy Forecast
10.3.4 Southeast Asia Market Natural Killer Cell Therapy Forecast
10.3.5 India Market Natural Killer Cell Therapy Forecast
10.3.6 Australia Market Natural Killer Cell Therapy Forecast
10.4 Europe Natural Killer Cell Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Natural Killer Cell Therapy Forecast
10.4.2 France Market Natural Killer Cell Therapy Forecast
10.4.3 UK Market Natural Killer Cell Therapy Forecast
10.4.4 Italy Market Natural Killer Cell Therapy Forecast
10.4.5 Russia Market Natural Killer Cell Therapy Forecast
10.5 Middle East & Africa Natural Killer Cell Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Natural Killer Cell Therapy Forecast
10.5.2 South Africa Market Natural Killer Cell Therapy Forecast
10.5.3 Israel Market Natural Killer Cell Therapy Forecast
10.5.4 Turkey Market Natural Killer Cell Therapy Forecast
10.6 Global Natural Killer Cell Therapy Forecast by Type (2026-2031)
10.7 Global Natural Killer Cell Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Natural Killer Cell Therapy Forecast
11 Key Players Analysis
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Information
11.1.2 Nektar Therapeutics Natural Killer Cell Therapy Product Offered
11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Nektar Therapeutics Main Business Overview
11.1.5 Nektar Therapeutics Latest Developments
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Information
11.2.2 Innate Pharma SA Natural Killer Cell Therapy Product Offered
11.2.3 Innate Pharma SA Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Innate Pharma SA Main Business Overview
11.2.5 Innate Pharma SA Latest Developments
11.3 Affimed
11.3.1 Affimed Company Information
11.3.2 Affimed Natural Killer Cell Therapy Product Offered
11.3.3 Affimed Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Affimed Main Business Overview
11.3.5 Affimed Latest Developments
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Information
11.4.2 Chipscreen Biosciences Natural Killer Cell Therapy Product Offered
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Chipscreen Biosciences Main Business Overview
11.4.5 Chipscreen Biosciences Latest Developments
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Information
11.5.2 Glycostem Therapeutics Natural Killer Cell Therapy Product Offered
11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Glycostem Therapeutics Main Business Overview
11.5.5 Glycostem Therapeutics Latest Developments
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Information
11.6.2 Fate Therapeutics Natural Killer Cell Therapy Product Offered
11.6.3 Fate Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Fate Therapeutics Main Business Overview
11.6.5 Fate Therapeutics Latest Developments
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Information
11.7.2 Dragonfly Therapeutics Natural Killer Cell Therapy Product Offered
11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Dragonfly Therapeutics Main Business Overview
11.7.5 Dragonfly Therapeutics Latest Developments
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Information
11.8.2 Kiadis Pharma Natural Killer Cell Therapy Product Offered
11.8.3 Kiadis Pharma Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Kiadis Pharma Main Business Overview
11.8.5 Kiadis Pharma Latest Developments
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Information
11.9.2 Nkarta Therapeutics Natural Killer Cell Therapy Product Offered
11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Nkarta Therapeutics Main Business Overview
11.9.5 Nkarta Therapeutics Latest Developments
11.10 NantKwest
11.10.1 NantKwest Company Information
11.10.2 NantKwest Natural Killer Cell Therapy Product Offered
11.10.3 NantKwest Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 NantKwest Main Business Overview
11.10.5 NantKwest Latest Developments
12 Research Findings and Conclusion